Company / Operating Income per Share
Inmune Bio, Inc. Operating Income per Share History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income per Share
-$1.91
FY2025
5-year range
-$1.91 / -$0.91
FY2021-FY2025
Trend
-15.5%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-1.45 to $-1.91 over the past 2 years.
Based on SEC 10-K filings.
-1.91 in FY2025.
Declined from $-1.45 to $-1.91 over the past 2 years.
Operating Income per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, operating income per share decreased 15.5% year-over-year.
- Peak operating income per share was recorded in FY2018.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score 49.46 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating Income per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$1.91 | -15.5% |
| FY2024 | -$1.66 | -14.6% |
| FY2023 | -$1.45 | +11.5% |
| FY2022 | -$1.63 | -80.1% |
| FY2021 | -$0.91 | -26.0% |
| FY2020 | -$0.72 | -510.4% |
| FY2018 | -$0.12 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026